Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > Spike RBD > EP-107

SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD)

For research use only.

Order Now

    Materials Provided
    IDComponentsSize
    EP107-C01Pre-coated Human ACE2 Microplate1 plate
    EP107-C02SARS-CoV-2 Inhibitor10 μg
    EP107-C03HRP-SARS-CoV-2 Spike RBD(WT)15 μg
    EP107-C0410xWashing Buffer50 mL
    EP107-C05Dilution Buffer50 mL
    EP107-C06Substrate Solution12 mL
    EP107-C07Stop Solution7 mL
  • Product Overview
    The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. The deleloped of effcient treatment agaginst SARS-CoV-2 is an emergent need for global pubic heath,and it is necessary to develop SARS-CoV-2 inhibitors, such as vaccines, therapeutic antibodies and small molecule compounds against SARS-CoV-2.

    Therefore, it is helpful to develop the SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors.

  • Application

    This kit is developed for screening inhibitors of SARS-CoV-2 (WT).

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

    Typical Data Please refer to DS document for the assay protocol.
     Spike RBD TYPICAL DATA

    Incubation of SARS-CoV-2 inhibitor:Blocking the binding of HRP-SARS-CoV-2 Spike RBD(WT) to Human ACE2.
    Serial dilutions of SARS-CoV-2 inhibitor (Catalog # EP107-C02) (1:1 serial dilutions, from 5.0ug/mL to 0.0098ug/mL(34.4nM to 0.07nM)) and loaded onto the plate coated by human ACE2 in the presence of HRP-SARS-CoV-2 Spike RBD(WT).Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

    • Clinical and Translational Updates

    Comments (0)

    Promotion & Exhibitions



    Datasheet & Documentation

    Request for DMF
    DMF (Drug Master File)

    New Product Launch

    Questions & Comments

    This web search service is supported by Google Inc.

    totop
    Call us
    Call us
    North America:
    +1 800-810-0816 (Toll Free)
    Asia & Pacific:
    +86 400-682-2521
    Fax
    Fax
    +1 888-377-6111
    Address
    Address
    1 Innovation Way, Newark, DE 19711, USA

    Leave a message